Interrupted Crosstalk between Natural Killer Cells and Anti-epidermal Growth Factor Receptor: A Possible Role in Hepatocellular Carcinoma Treatment Failure.

Abosalem, Hadeer; Mahgoub, Shahenda; Emara, Mohamed; Kotb, Nahla; Soror, Sameh

Abosalem, Hadeer; Mahgoub, Shahenda; Emara, Mohamed; Kotb, Nahla; Soror, Sameh.

Afiliación

Abosalem H; Biotechnology Unit, Egyptian Drug Authority (EDA), Giza, 12654, Egypt.
Mahgoub S; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo 11795, Egypt.
Emara M; Department of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo,11795, Egypt.
Kotb N; Manager of Blood Derivative Unit, Egyptian Drug Authority (EDA), Giza, 12654, Egypt.
Soror S; Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Helwan University, Ein-Helwan, Helwan, Cairo 11795, Egypt.

Curr Cancer Drug Targets ; 21(7): 601-607, 2021.

Article en En | MEDLINE | ID: mdl-34011259

Asunto(s)

Carcinoma Hepatocelular; Neoplasias Hepáticas; Citotoxicidad Celular Dependiente de Anticuerpos; Carcinoma Hepatocelular/tratamiento farmacológico; Humanos; Células Asesinas Naturales; Neoplasias Hepáticas/tratamiento farmacológico; Insuficiencia del Tratamiento

Palabras clave

ADCC.; HCC immunotherapy; NK; anti-EGFR mAb; molecular target therapy; tumor microenvironment

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Curr Cancer Drug Targets Asunto de la revista: ANTINEOPLASICOS / NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google